Aivolosin has received marketing authorisation in Indonesia for poultry, the No.1 market in Southeast Asia and the eighth largest globally for laying birds. This approval represents another important step in the global rollout of Aivlosin as a treatment of choice for a variety of respiratory and enteric diseases in both poultry and swine, and expands Aivlosin’s commercial reach into a substantial market. Latest estimates put the Indonesian chicken layer population at 166m1. We reiterate
30 Jan 2020
Marketing authorisation for Aivlosin in Indonesia
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Marketing authorisation for Aivlosin in Indonesia
ECO Animal Health Group plc (EAH:LON) | 94.0 0 0.0% | Mkt Cap: 63.7m
- Published:
30 Jan 2020 -
Author:
Edward Thomason -
Pages:
3
Aivolosin has received marketing authorisation in Indonesia for poultry, the No.1 market in Southeast Asia and the eighth largest globally for laying birds. This approval represents another important step in the global rollout of Aivlosin as a treatment of choice for a variety of respiratory and enteric diseases in both poultry and swine, and expands Aivlosin’s commercial reach into a substantial market. Latest estimates put the Indonesian chicken layer population at 166m1. We reiterate